This suggests that elevated levels of miR-664b-3p can suppress Rheb expression, thereby inhibiting downstream mTORC1 activity and reducing c-MYC-mediated metabolic reprogramming, a hallmark of cancer progression. The gene discussed is RHEB; the disease is cancer.